A recent study by University College Galway and international colleagues has identified critical targets in the molecular signature of Parkinson’s disease, potentially leading to the development of glycan-focused therapeutic devices for treatment and diagnosis. Researchers at CÚRAM, along with collaborators, published their work in the journal PNAS Nexus, shedding light on the complex role of sugars (glycans) in cell-to-cell communication in the brain affected by Parkinson’s. The study could pave the way for advancements in understanding and treating neurodegenerative diseases beyond Parkinson’s, with implications for future research and therapeutic approaches.
Source link
Galway researchers discover critical targets in the molecular signature of Parkinson’s
